Copenhagen University Hospital at Herlev Clinical Trials
Sponsors / Copenhagen University Hospital at Herlev
ClinicalTrials.gov lists 93 trials for which Copenhagen University Hospital at Herlev is named as lead sponsor. The portfolio currently includes 12 recruiting studies, 2 active non-recruiting studies, and 48 completed studies. 11 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include slow or insufficient recruitment, efficacy or futility findings. Cumulative planned enrollment across all listed trials is 78,941 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.
93
Total Trials
12
Recruiting
2
Other Active
48
Completed
11
Terminated / Withdrawn
78,941
Total Enrollment
Termination reasons: Other55% · Recruitment27% · Efficacy9% · Safety9%
Recent Terminations
- Contact Dermatitis Irritant"Stopped after 17/20 participants due to lack of time after a prolonged recrutiment period."
- NCT02494388 Stopped Jun 2017Cystadenocarcinoma
- NCT02481687 Stopped Jun 2017Crohn's Disease
- Infertility"Failure to recruit participants"
- Malignant Melanoma"Diminished rectruitment"
- Metastatic Malignant Neoplasm"Production of the IMP (plasmid AMEP) has been terminated by the supplier (BioAlliance Pharma)"
- Hysterectomy"Due to local restructering, further recruting was not possible"
- Brain Metastases"Due to slow patient recruitment"
- Stress Urinary Incontinence"Failure to recruit participants"
- Breast Cancer"Primary endpoint measure not suitable for evaluation"
Active Trials (2 total)
- NCT07549880
- Infection NANCT07458763
- NCT06636487
- Diabetic Kidney Disease PHASE2NCT06600412
- Anemia PHASE4NCT06898814
- In Vitro Fertilization (IVF) PHASE3NCT07108621
- Colon Cancer NANCT06802991
- NCT06214988
- NCT06259279
- NCT03160131
- NCT04401462
- NCT04576169
- NCT01882205
- NCT05838079